MedTrace Logo

Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain

NCT00737191 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2012-03-09

No results posted yet for this study

Summary

RATIONALE: Opioids lessen pain caused by cancer. It is not yet known whether opioids are more effective when given together with or without olanzapine in treating cancer pain.

PURPOSE: This randomized clinical trial is studying opioids to see how well they work when given together with or without olanzapine in treating patients with moderate to severe cancer pain.

Conditions

  • Hematopoietic/Lymphoid Cancer
  • Pain
  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

olanzapine

Given orally

OTHER

placebo

Given orally

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Eric E. Prommer, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-11-30
Completion
2009-11-30

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00737191 on ClinicalTrials.gov